RIO – AFIC 2023
Towards the middle of March, The Paxman France team visited RIO 2023. Aimed at Oncology Nurses, the event was organized by AFIC (French Association of Oncology Nurses) and the theme was “Care one day for those who care every day”.
It was great to see AFIC’s president, Pascale Dielenseger, organize such an insightful agenda – and our team networked with many nurses discussing how scalp cooling can fit into their care agendas.
St. Gallen Breast Cancer Conference
Taking place in Vienna, Austria – our International Team visited the St. Gallen Breast Cancer Conference (SGBCC). Patients, patient advocates, and charities were among the attendees, as well as clinicians and nurses from an international audience.
During the event, the team spent some time with the president of Europa Donna Albania, Donjeta Zeqa. Europa Donna is a non-profit organization who works to increase education, research funding, and awareness of breast cancer in Europe and are an amazing advocate for women across Europe. Europa Donna also focuses on personalized treatment plans, survivorship care, and improving quality of life for patients – topics that scalp cooling seamlessly fits into.
Community Oncology Alliance
Over in Florida, our team in the US attended the Community Oncology Alliance (COA). Looking to improve the future of patient-centered care, the conference’s theme for 2023 was ‘Adapt, Evolve & Transform’. The event featured keynote speaker, Will Flanary, also known as Dr. Glaucomflecken on TikTok, who is a two-time cancer survivor and practicing ophthalmologist.
Whilst attending, the USA team also discussed our new Reimbursement Business Model and Patient Assistance Programme with delegates, which is now available in multiple healthcare systems across the US. You can find out more about this, here.
Society of Gynaecological Oncology (SGO) Annual Meeting on Women’s Cancer
The Society of Gynaecological Oncology (SGO) meets annually for an event on Women’s Cancer. This year’s event in Florida included presentations from several impressive guest speakers.
One specific session presented findings of a clinical trial investigating cryocompression for chemotherapy-induced peripheral neuropathy (CIPN) treatment. CIPN is a previously under-researched chemotherapy side-effect but can be debilitating for patients during and after chemotherapy. The session led by Mary Katherine Anasasio and Laura J Havrilesky, reported an incidence rate of 30%-40% without preventative measures – and the trial concluded that cryocompression prevented subjective neuropathy.
This proposes promising results for the upcoming SWOG clinical trial investigating the efficacy of the Paxman Limb Cryocompression System (PLCS) in mitigating and preventing CIPN.
Read more about the upcoming trial, here.